Dennis Liotta
Gründer bei Centrosome Ventures LLC
Profil
Dr. Liotta obtained his PhD degree at City University of New York and carried out postdoctoral research at Ohio State University, after which he joined the Emory faculty in 1976.
He was promoted to full professor in 1988 and currently holds the Samuel Candler Dobbs Professorship at Emory.
To date, he has supervised over 150 graduate and post-graduate students.
In 2011 he was honored with the Thomas Jefferson Award, Emory University’s highest service award.
Earlier he served as the chair of the chemistry department and as Emory’s vice president for research.
He has published approximately 290 peer-reviewed research publications and holds over 90 issued US patents as of November 2019.
He is most noted for his invention of emtricitabine, along with Drs.
Raymond F.
Schinazi and Woo-Baeg Choi.
This breakthrough HIV drug, currently marketed under the name Emtriva, is a component of a number of combination therapies used to treat HIV, including Truvada, Atripla, Complera, Stribild, Genvoya, Odefesey, Biktarvy and Descovy.
Truvada is the only combination therapy approved for Pre-Exposure Prophylaxis (PrEP).
Drs.
Liotta, Schinazi and Choi also co-invented Epivir (lamivudine), which is a component of multiple combination therapies such as Combivir, Trizivir, Epzicom, Triumeq, Dutrebis and Delstrigo.
It is estimated that >90% of HIV infected patients in the US take or have taken drug combinations that include either Emtriva or Epivir.
In addition to these academic achievements, he was one of the founders of Pharmasset, Inc., which developed the breakthrough anti-hepatitis C drug, Sovaldi (sofosbuvir) and was subsequently acquired by Gilead Sciences.
Currently, he is the director of the Emory Institute for Drug Development and co-founder of DRIVE (Drug Innovation Ventures at Emory) and the founding editor-in-chief of the American Chemical Society journal, ACS Medicinal Chemistry Letters.
Aktive Positionen von Dennis Liotta
| Unternehmen | Position | Beginn |
|---|---|---|
Centrosome Ventures LLC
 Centrosome Ventures LLC Investment ManagersFinance Centrosome Ventures LLC (Centrosome Ventures) is a venture capital firm founded in 2005 by Dennis C. Liotta. The firm is headquartered in Atlanta, Georgia. | Gründer | 15.02.2011 |
| Emory University | Corporate Officer/Principal | 09.09.2009 |
FOB Synthesis, Inc.
 FOB Synthesis, Inc. Chemicals: Major DiversifiedProcess Industries FOB Synthesis, Inc. is a hybrid chemical company. The private company is based in Kennesaw, GA. | Private Equity Investor | - |
NeurOp, Inc.
 NeurOp, Inc. Pharmaceuticals: MajorHealth Technology NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and alzheimer's and parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA. | Private Equity Investor | - |
| iThemba Pharmaceuticals Pty Ltd. | Private Equity Investor | - |
| Drug Innovation Ventures At Emory LLC | Private Equity Investor | - |
QUE Oncology, Inc.
 QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Private Equity Investor | - |
VIC Technology Venture Development LLC
 VIC Technology Venture Development LLC Investment ManagersFinance VIC Technology Venture Development LLC (VIC Technology) is a venture capital firm founded in 2000 by Calvin R. Goforth. The firm is headquartered in Fayetteville, Arkansas. | Berater | - |
Ehemalige bekannte Positionen von Dennis Liotta
| Unternehmen | Position | Ende |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Independent Dir/Board Member | 08.06.2015 |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░ ░░░░ ░░░░░░░░░░░ | ░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Ausbildung von Dennis Liotta
| City University of New York | Doctorate Degree |
| Queens College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 15 |
|---|---|
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
Altiris, Inc.
 Altiris, Inc. Packaged SoftwareTechnology Services Altiris, Inc. provides management software products and services. The company enables organizations to align business through lifecycle management, automated operations, and enforceable security. It also offers consulting, implementation, and support services. Altiris was founded in 1998 and is headquartered in Lindon, UT | Technology Services |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Metastatix, Inc.
 Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA. | Health Technology |
Altiris Therapeutics, Inc.
 Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Health Technology |
Centrosome Ventures LLC
Centrosome Ventures LLC Investment ManagersFinance Centrosome Ventures LLC (Centrosome Ventures) is a venture capital firm founded in 2005 by Dennis C. Liotta. The firm is headquartered in Atlanta, Georgia. | Finance |
NeurOp, Inc.
NeurOp, Inc. Pharmaceuticals: MajorHealth Technology NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and alzheimer's and parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA. | Health Technology |
FOB Synthesis, Inc.
FOB Synthesis, Inc. Chemicals: Major DiversifiedProcess Industries FOB Synthesis, Inc. is a hybrid chemical company. The private company is based in Kennesaw, GA. | Process Industries |
| iThemba Pharmaceuticals Pty Ltd. | |
| Drug Innovation Ventures At Emory LLC | |
Emory Institute For Drug Development
 Emory Institute For Drug Development Miscellaneous Commercial ServicesCommercial Services Emory Institute For Drug Development engages in drug discovery and development in industry and academia. It provides organization, facilities and resources to translate academic drug discovery into clinical candidates. The company was founded by Dennis C. Liotta in 2009 and is headquartered in Atlanta, GA. | Commercial Services |
VIC Technology Venture Development LLC
VIC Technology Venture Development LLC Investment ManagersFinance VIC Technology Venture Development LLC (VIC Technology) is a venture capital firm founded in 2000 by Calvin R. Goforth. The firm is headquartered in Fayetteville, Arkansas. | Finance |
QUE Oncology, Inc.
QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Health Technology |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Altesa BioSciences, Inc. develops oral recombinant vaccines. The company is based in College Park, GA. The company was founded by Dennis C. Liotta, George R. Painter, Seth A. Rudnick, John M. Clerici, Samuel Candler Dobbs. The CEO is Brett P. Giroir. | Health Technology |
